June 2018 FDA Recall Drug by Pfizer
D-1023-2018 - Microbial Contamination of Sterile Products

This Class II drug recall was voluntarily initiated by Pfizer on June 28, 2018 for the product Drug. The FDA reported the reason for recall as microbial contamination of sterile products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1023-2018

Reason for Recall
Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.
Initiated
06-28-2018
Reported
08-08-2018
Quantity
234,680 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA and Puerto Rico.
Daptomycin for Injection, 500 mg per vial, packaged as 1 Single-dose vial per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-0106-01.

Batch or Lot Expiration Information

Lot# : 712453A, Exp 1-Nov-18; 771803A, Exp 1-May-19; 792103A, Exp 1-Jul-19; 800903A, Exp 1-Aug-19; 810853A, Exp 1-Sep-19; 841703A, 841753A, Exp 1-Dec-19; 850553A, Exp 1-Jan-20.